Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study
<p>Abstract</p> <p>Background</p> <p>The primary objective of this study was to investigate if supplementary lactobacilli treatment could improve the initial cure rate after vaginal clindamycin therapy, and secondly, if lactobacilli as repeated adjunct treatment during...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-01-01
|
Series: | BMC Women's Health |
Online Access: | http://www.biomedcentral.com/1472-6874/8/3 |